FDAnews
www.fdanews.com/articles/61694-gilead-inks-hiv-drug-distribution-deal-with-merck

GILEAD INKS HIV DRUG DISTRIBUTION DEAL WITH MERCK

August 14, 2006

Gilead Sciences Inc. agreed to a manufacturing and distribution deal for the HIV drug Atripla with Merck & Co. Foster City-based Gilead will make the tablets — a combination of three HIV drugs in one pill — using one of the drugs, efavirenz, supplied by Merck. The other two components are Gilead drugs. Merck will then distribute the tablets in developing countries.
Yahoo Finance